Can We Achieve 'high-quality' Weight Loss Through Supplementation and Exercise? the TRIM MUSCLE Study
NCT ID: NCT05384431
Last Updated: 2025-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
51 participants
INTERVENTIONAL
2022-08-15
2024-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vegan Whey Protein for Muscle Anabolism and Post-exercise Recovery
NCT07119749
Strategic Ingestion of Creatine Supplementation and Resistance Training in Trained Young Adults
NCT06438887
Effects of Resistance-band Training and Creatine and Whey Protein
NCT06606717
Effect of Strength Versus Endurance Training on Muscle Damage in Gym Athletes on Caffeine Supplementation.
NCT06086691
The Effect of Creatine on Muscle Loss
NCT01894737
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary objective/research question\*:
-Can the addition of TRIM 7 and MUSCLE 5 to an exercise program induce greater 'high-quality' weight loss?
Co-primary objectives/research questions\*:
* Can the addition of TRIM 7 and MUSCLE 5 to an exercise program induce greater loss of bodyweight?
* Can the addition of TRIM 7 and MUSCLE 5 to an exercise program induce greater improvement in body mass index (BMI)?
* Can the addition of TRIM 7 and MUSCLE 5 to an exercise program induce greater improvement in waist-to-hip ratio?
* Can the addition of TRIM 7 and MUSCLE 5 to an exercise program induce greater loss of fat mass?
* Can the addition of TRIM 7 and MUSCLE 5 to an exercise program maintain or improve lean mass?
* Can the addition of TRIM 7 and MUSCLE 5 to an exercise program maintain or improve lean mass/fat mass ratio (e.g., body composition index)?
Secondary objectives/research questions:
* Can the addition of TRIM 7 and MUSCLE 5 to an exercise program induce greater improvements in muscle strength and aerobic capacity?
* Can the addition of TRIM 7 and MUSCLE 5 to an exercise program induce greater improvements in insulin sensitivity?
* Can the addition of TRIM 7 and MUSCLE 5 to an exercise program induce greater reductions in inflammation and greater increases in antioxidant status?
* Can the addition of TRIM 7 and MUSCLE 5 to an exercise program induce greater improvements in sleep quality, perceived stress, health-related quality of life and the overall health index?
* Can the addition of TRIM 7 and MUSCLE 5 to an exercise program induce greater improvements in hair \& nail growth?
Hypotheses:
* The addition of TRIM 7 and MUSCLE 5 will induce greater 'high-quality' weight loss than exercise alone as evidenced by A) greater loss of fat mass, B) greater gain (or maintenance) of lean mass, C) greater improvement in lean mass/fat mass ratio (e.g., body composition index) D) greater loss of bodyweight E) greater reduction in waist-to-hip ratio and/or F) greater improvement in BMI.
* The addition of TRIM 7 and MUSCLE 5 will induce greater improvements in muscle strength and aerobic fitness than exercise alone as evidenced by a greater improvement in 1RM and VO2peak than exercise alone.
* The addition of TRIM 7 and MUSCLE 5 will induce greater improvements in insulin sensitivity (HOMA-IR, glycemic control during an OGTT, Matsuda Index) than exercise alone.
* The addition of TRIM 7 and MUSCLE 5 will induce a greater reduction in inflammation (TNFα, IL6, CRP, IL- 10) and induce a greater improvement in antioxidant status (GSH:GSSG, CuZn SOD, MnSOD, catalase, total reducing capacity of plasma) than exercise alone.
* The addition of TRIM 7 and MUSCLE 5 will induce greater improvements in sleep quality, perceived stress, health-related quality of life, and an overall health index than exercise alone.
* The addition of TRIM 7 and MUSCLE 5 will induce greater improvements in hair \& nail growth than exercise alone.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Muscle5 and TRIM7
MUSCLE5 and TRIM7 natural health product supplementation
Name of natural health product (brand name, generic) - MUSCLE 5, chocolate Is this a market-approved natural health product (per Health Canada)? - Yes Dose - 1 scoop Ingredients (per dose) - Whey protein isolate (24g), milk protein isolate (16g), Creatine (3g), Calcium (450mg), Vitamin D (1000 IU) Frequency of administration - Once/day Duration (e.g., six weeks) - 12 weeks Route of administration - Oral
Name of natural health product (brand name, generic) - TRIM7 Is this a market-approved natural health product (as per Health Canada)? Yes Dose - 3 capsules Ingredients (per dose) - Alpha lipoic acid (200mg), CoEnzyme Q10 (100mg), beet root extract (250mg), green coffee bean extract (250mg), green tea extract (250mg), forskolin (25mg), Vitamin E (22 mg AT) Frequency of administration - Twice/day Duration (e.g., six weeks) - 12 weeks Route of administration - Oral
Muscle5 and TRIM7
Intake of MUSCLE 5 and TRIM 7 supplements on a daily basis for 12 weeks
Mixed exercise
Mixed exercise (aerobic and resistance) three days per week for 12 weeks
Placebo
Placebo collagen and microcrystalline cellulose intake
Placebo Control 1 (Counter to MUSCLE5) Dose - 1 scoop Ingredients (per dose) - Collagen (40g) Frequency of administration - once/day Duration - 12 weeks Route of administration - Oral
Placebo Control 2 (Counter to TRIM7) Dose - 3 capsules Ingredients (per dose) - Microcrystalline cellulose (400 mg) Frequency of administration - twice/day Duration - 12 weeks Route of administration - Oral
Mixed exercise
Mixed exercise (aerobic and resistance) three days per week for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Muscle5 and TRIM7
Intake of MUSCLE 5 and TRIM 7 supplements on a daily basis for 12 weeks
Mixed exercise
Mixed exercise (aerobic and resistance) three days per week for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \> 25 kg/m2
* low physical activity level \< 150 min/week (\< ACSM and CSEP recommendations)
* have had two doses of the COVID-19 vaccine
Exclusion Criteria
* liver disease (i.e. diagnosed NAFLD, NASH, cirrhosis, previous liver transplant)
* GI disorders (i.e. Colitis, Crohns)
* cardiovascular disease (recent myocardial infarction (\< 6 months), hypertension requiring more than 2 medications, congestive heart failure requiring more than one medication for control, unstable arrhythmia, angina previous stroke with residual hemiparesis)
* severe osteoarthritis
* significant weight loss in the 3-month period prior to the study (10% of total body weight)
* muscular dystrophy
* severe peripheral neuropathy
* severe osteoporosis
* uncontrolled hypertension (\>140/90 mmHg)
* orthopedic problems
* type I or II diabetes
* respiratory conditions (i.e. chronic pulmonary obstructive disorder), chronic obstructive pulmonary disease (FVC or FEV1 \< 70% of age predicted mean value), and asthma requiring more than two medications
* individuals with prior bariatric surgery
* women who have ammenorrhea, dysregulated menstrual cycle, are peri-menopausal, menopausal, pregnant, looking to become pregnant, or nursing
* medications, including anti-inflammatory medications, more than one glucose lowering medication, insulin, platelet inhibitors, anti-coagulant medications, or Simvastatin (zocor), beta-blockers, or weight loss medications (Orlistat, Saxenda Contrave) or any other medications known to affect protein metabolism (i.e.corticosteroids).
* inability to take part in the exercise program
* vegan
* smoking
* history of glaucoma or
* overactive bladder syndrome
* consumption of more than 10 drinks/week or 2 drinks/d for women and 15 drinks/week or 3 drinks/d for men.
* history of allergy, sensitivity or strong dislike towards any component of the study products (supplements)
* have undergone a barium swallow or an infusion of a contrast agent in the past 3 weeks
* have an implantable electronic device
* inability to perform exercise as determined by the Get Active Questionnaire (GAQ)
* inability to consent
* participants on volitional dietary supplements will be considered on a case-by-case basis, but they will be asked to refrain from intake for at least 2 weeks prior to partaking in this study.
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Waterloo
OTHER
Exerkine Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michaela Devries-Aboud, PhD
Role: PRINCIPAL_INVESTIGATOR
Kinesiology and Health Sciences, University of Waterloo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Michaela Devries-Aboud
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
43396
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.